ShareCompartir
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Notes from the Field: Measles Transmission Associated with International Air Travel --- Massachusetts and New York, July--August 2010
On July 8, 2010, the Massachusetts Department of Public Health (MDPH) notified CDC of a case of laboratory-confirmed measles in an unvaccinated airline passenger aged 23 months (1). The child had arrived hours earlier on a flight from Switzerland and was contagious during the flight. After obtaining the flight manifest, CDC shared locating information with relevant state health departments; of 31 passengers considered exposed (i.e., seated within two rows and any infant seated anywhere on the airplane), 29 (94%) were notified.
On July 28, the New York State Department of Health (NYSDOH) notified CDC and MDPH that one of the airline contacts had developed laboratory-confirmed measles. The ill traveler came to the United States as a chaperone for students from Europe and Asia attending an educational program. During July 20--23 (while contagious and before being isolated), he exposed 270 students and counselors in Massachusetts and New York. Member of this group were scheduled to return to their home countries from July 30 through August 6. Because exposed, susceptible persons who are incubating measles might be infectious 5--21 days after initial exposure, the surveillance period was determined to be until August 14 (2,3). CDC Quarantine Stations in Boston and New York worked with NYSDOH and MDPH to assess the immune status of contacts before permitting them to fly. Presumptive evidence of immunity to measles was defined as 1) documentation of at least 1 dose of measles-containing vaccine or 2) serologic evidence of immunity.
Of the 270 persons considered exposed, 268 (99%) were cleared to fly as scheduled: 242 provided documentation of vaccination and 26 had serologic evidence of immunity. Two persons lacked evidence of immunity and voluntarily postponed their departures until the end of the surveillance period. CDC requested that the airlines waive any fees for changing flights. No febrile rash illnesses have been reported among exposed persons.
To prevent the spread of measles, international travelers are encouraged to have evidence of measles immunity. Persons with measles or those who might be incubating measles should avoid travel aboard commercial airlines until they are no longer infectious. Organizations hosting international students should consider asking participants to provide documentation of adequate vaccination.
Reported by
N Cocoros, MPH, R Hernandez, MPH, N Harrington, Massachusetts Dept of Public Health; E Rausch-Phung, MD, CR Schulte, D Blog, MD, New York State Dept of Health. K Gallagher, DSc, Div of Viral Diseases, National Center for Immunization and Respiratory Diseases; A Klevos, MPH, C Kim, MD, N Marano, DVM, F Alvarado-Ramy, MD, Div of Global Migration and Quarantine, National Center for Emerging and Zoonotic Infectious Diseases, CDC.
Acknowledgment
The findings in this report are based, in part, on contributions by the Westchester County Dept of Health, New York.
References
- CDC. Case definitions for infectious conditions under public health surveillance. Available at http://www.cdc.gov/ncphi/disss/nndss/casedef/index.htm. Accessed August 23, 2010.
- CDC. Manual for the surveillance of vaccine-preventable diseases, 4th ed. Atlanta, GA: US Department of Health and Human Services, CDC; 2009. Available at http://www.cdc.gov/vaccines/pubs/surv-manual/default.htm. Accessed August 5, 2010.
- CDC. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998;47(No. RR-8).
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All MMWR HTML versions of articles are electronic conversions from typeset documents.
This conversion might result in character translation or format errors in the HTML version.
Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr)
and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S.
Government Printing Office (GPO), Washington, DC 20402-9371;
telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
